LEASELease • September 26th, 1997 • Immunogen Inc • Pharmaceutical preparations
EXHIBIT 10.34 IMMUNOGEN, INC. HAS OMITTED FROM THIS EXHIBIT 10.34 PORTIONS OF THE AGREEMENT FOR WHICH IMMUNOGEN, INC. HAS REQUESTED CONFIDENTIAL TREATMENT FROM THE SECURITIES AND EXCHANGE COMMISSION. THE PORTIONS OF THE AGREEMENT FOR WHICH...Stock Purchase Agreement • September 26th, 1997 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
WITNESSETH:License Agreement • September 26th, 1997 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
WITNESSETH:Research Collaboration Agreement • September 26th, 1997 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
EXHIBIT 10.36 APOPTOSIS TECHNOLOGY, INC. REGISTRATION AGREEMENT THIS AGREEMENT is made as of July 31, 1997 between Apoptosis Technology, Inc., a Massachusetts corporation (the "Company"), and BioChem Pharma (International) Inc., a Canadian corporation...Registration Agreement • September 26th, 1997 • Immunogen Inc • Pharmaceutical preparations
1 EXHIBIT 10.10 CONFIRMATORY SECOND AMENDMENT TO LEASE Reference is hereby made to a Lease dated June 21, 1988, as amended (the "Lease") by and between James H. Mitchell, Trustee of New Providence Realty Trust, as Lessor ("Lessor"), and ImmunoGen,...Immunogen Inc • September 26th, 1997 • Pharmaceutical preparations
1 EXHIBIT 10.35 IMMUNOGEN, INC. REGISTRATION AGREEMENT THIS AGREEMENT is made as of July 31, 1997 between ImmunoGen, Inc., a Massachusetts corporation (the "Company"), and BioChem Pharma (International) Inc., a Canadian corporation ("BioChem"). The...Registration Agreement • September 26th, 1997 • Immunogen Inc • Pharmaceutical preparations
